黑料网

Atherosclerosis is a progressive condition characterized by the accumulation of lipids, inflammatory cells, and smooth muscle cells within the arterial walls, leading to the formation of plaques. Over time, these plaques can narrow and harden arteries, disrupting blood flow and leading to serious cardiovascular events, including coronary artery disease (CAD), heart attacks, and strokes. One of the critical processes involved in atherosclerosis is angiogenesis, the formation of new blood vessels from pre-existing ones, which occurs in response to the increased metabolic demands of the expanding plaque. Angiogenic factors, such as vascular endothelial growth factor (VEGF), fibroblast growth factors (FGFs), and angiopoietins, play key roles in this process. While angiogenesis is often seen as a response to ischemia aimed at restoring blood supply, within atherosclerotic lesions, these angiogenic factors can have both beneficial and detrimental effects on plaque stability. This article explores the impact of angiogenic factors on the progression of atherosclerosis and their role in the development and exacerbation of coronary artery disease [1].

Description

The role of angiogenesis in atherosclerosis

As atherosclerotic plaques grow, they may become hypoxic due to limited blood flow, especially in the plaque’s core. Hypoxia, a state of low oxygen availability, is a potent trigger for angiogenesis, as the body attempts to restore oxygen supply to the affected tissue. The process is driven by angiogenic factors, which stimulate endothelial cells to proliferate, migrate, and form new blood vessels. These new vessels are intended to improve oxygenation; however, within the setting of atherosclerosis, they often become structurally abnormal, contributing to plaque progression and instability [2].

The relationship between angiogenesis and atherosclerosis is complex. While angiogenesis is a necessary response to ischemia, the newly formed vessels in atherosclerotic plaques are typically dysfunctional [3]. They tend to be fragile, leaky, and prone to rupture, which can exacerbate the inflammatory response within the plaque, leading to plaque growth, rupture, and thrombosis. Therefore, angiogenic factors are double-edged swords on one hand, they attempt to improve blood flow, but on the other hand, they can destabilize the plaque and increase the risk of acute cardiovascular events.

Angiogenic factors and their impact on atherosclerotic lesions

Several key angiogenic factors are involved in the process of angiogenesis within atherosclerotic lesions. These factors can promote plaque growth and instability, depending on the context in which they are activated.

Angiopoietins: Angiopoietins are a family of proteins involved in the regulation of blood vessel maturation and stability. Angiopoietin-1 (Ang-1) promotes endothelial cell survival and stabilizes blood vessels by interacting with the Tie-2 receptor [4]. In contrast, angiopoietin-2 (Ang-2) promotes vessel destabilization and increases vascular permeability. In atherosclerotic lesions, the balance between Ang-1 and Ang-2 is crucial for determining the stability of newly formed blood vessels. An overexpression of Ang-2 can contribute to the formation of leaky, fragile vessels, which can increase the risk of plaque rupture and thrombosis.

Platelet-derived growth factor: PDGF is another important factor in angiogenesis that also plays a significant role in smooth muscle cell proliferation and migration. In atherosclerotic plaques, PDGF contributes to the recruitment of smooth muscle cells to the intima, where they help form the fibrous cap that surrounds the lipid-rich core of the plaque. However, excessive PDGF signaling can contribute to the thickening of the intima and the development of plaque fibrosis, which can lead to the formation of calcified lesions. This increased fibrosis can exacerbate the mechanical stress on the plaque, further promoting instability [5].

The dual nature of angiogenesis in atherosclerosis

Angiogenesis in atherosclerotic lesions has a dual role: while it may be beneficial in restoring blood flow to ischemic tissues, it also contributes to the destabilization of plaques. The newly formed blood vessels, although initially formed to improve oxygen delivery, often become dysfunctional. They are frequently leaky, prone to rupture, and contribute to further inflammation within the plaque. This creates a vicious cycle, in which angiogenesis promotes both plaque expansion and instability [6].

The Role of Angiogenic Factors in Coronary Artery Disease (CAD)

In coronary artery disease, the impact of angiogenic factors on plaque progression and instability is particularly relevant. The coronary arteries are especially susceptible to the development of atherosclerotic plaques due to the high blood flow and pressure within these vessels. As plaques grow and become hypoxic, angiogenesis is initiated, but the new vessels may contribute to the weakening of the fibrous cap, increasing the likelihood of rupture [7]. This rupture can lead to the formation of a thrombus, which can occlude the artery and result in a myocardial infarction (heart attack).

Clinical relevance and implications

The impact of angiogenic factors on the progression of atherosclerosis and coronary artery disease has important clinical implications. Understanding the complex role of angiogenesis in plaque formation and destabilization could lead to more effective therapeutic strategies for managing atherosclerosis and CAD.

Targeted therapies: Developing therapies that can selectively modulate angiogenesis may help treat patients with advanced atherosclerosis. For example, therapies that inhibit VEGF or Ang-2 could be used to stabilize plaques and reduce the risk of rupture. On the other hand, in patients with chronic ischemia, promoting angiogenesis through VEGF or FGF may help restore blood flow to ischemic tissues [8].

Conclusion

Angiogenic factors play a crucial role in the progression of atherosclerosis and the development of coronary artery disease. While angiogenesis is a natural response to ischemia, it can have both beneficial and harmful effects in the context of atherosclerotic lesions. Angiogenic factors such as VEGF, FGF, Ang-2, and PDGF are involved in the formation of new blood vessels within plaques, but the resulting vessels are often dysfunctional and contribute to plaque instability. The dual nature of angiogenesis highlights the need for precise therapeutic strategies that either promote or inhibit angiogenesis, depending on the clinical context. As research into angiogenesis and its role in cardiovascular disease continues, we may see the development of more targeted therapies that can stabilize plaques, reduce the risk of acute cardiovascular events, and improve patient outcomes.

Acknowledgement

None

Conflict of Interest

None

References

1. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G (2000) Ann N Y Acad Sci 902: 230-239.

, ,

2. Campbell KA, Lipinski MJ, Doran AC, Skaflen MD, Fuster V, et al. (2012) Circ Res 110: 889-900.

, ,

3. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, et al. (1999) Atherosclerosis 145: 33-43.

, ,

4. Libby P, Ridker PM, Hansson GK (2011) Nature 473: 317-325.

, ,

5. Camejo G, Lalaguna F, Lopez F, Starosta R (1980) Atherosclerosis 35: 307-320.

, ,

6. Tabas I, Williams KJ, Boren J (2007) Circulation 116: 1832-1844.

, ,

7. Frostegard J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H, (1990) . Proc Natl Acad Sci USA 87: 904-908.

, ,

8. Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, et al. (1992) Arterioscler Thromb 12: 461-467.

, ,